First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
He has published more than 100 research papers in several prestigious national and international journals
Post the sale, Patel family has become the single largest promoter shareholder in the company
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Subscribe To Our Newsletter & Stay Updated
